Main Subject - Business

I'm an alumni of Boston University Graduate School of Management, so I receive the Alumni magazine Bostonia. To be honest, that doesn't mean I read it faith

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

fully at all. But this issue was different. George Labovitz, a professor in organizational behavior at the school wrote an article recently on his research

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

nto the application of alignment to achieve extraordinary results in organizations.

He caught me with the first sentence: "More than thirty years of resear

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ch has shown that aligned and integrated organizations outperform their nearest competitors in every major financial measure."

He admitted not many organiz

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

tions do it, but those that utilize it well also realize a significant competitive advantage!

By definition: alignment is the optimal state in which strate

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

gy, people, customers, and key processes work in concert to propel growth and profits. When business leaders implement this kind of alignment, the whole org

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

nization enjoys greater customer satisfaction, employee satisfaction, greater returns for investors. To do this, they de-emphasize hierarchy and distribute

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

authority, information, knowledge, and customer data. As a result, every employee top to bottom, understands the strategy and goals of the business. Consequ

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ntly, everyone knows how his/her work contributes to it.

There are many ways to measure alignment. But you can only achieve alignment across the board thro

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ugh distributed leadership. Implementing such strategies develops leadership in each unit of your operation and at different levels of your organization. Yo

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

actually end up empowering employees to act and give them the knowledge about what must be done.

With this kind of clear vision and strong communication,

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ou can allow your team to run with tasks and projects independent of your day-to day management, freeing you for higher level leadership tasks and responsib

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ilities.

With this kind of clear vision and strong communication, you can allow your team to run with tasks and projects independent of your day-to day man

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

gement, freeing you for higher level leadership tasks and responsibilities.

* Keep people connected - so they know what is at stake.

* Help people think h

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

olistically. You can't expect them to make good decisions if they can't see the big picture.

* Keep people connected to the company vision, mission and goa

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

s - raise the horizon of understanding so they are not limited to seeing only department or job specific goals.

* Reward and recognize people for working t

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

oward the main goal - not just department goals.

* How you bring this into the review process will drive it home for future behavior.

*Create opportunitie

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

for people to interact - they work better with people they know personally and can empathize with.

* Make the process iterative - taking action is not a o

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ne-time thing.

To answer the question I posed: Why bother? Is it worth it? I think so. These are the same tactics we all need to cultivate in business and

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

rganizations, to make the leap from good to great. Excellence is like the family silver, the more you use it and polish it up regularly, the better it looks

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/3148/mainsubjects-Why-Bother-With-Distributed-Leadership.html">Why Bother With Distributed Leadership?</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/3148/mainsubjects-Why-Bother-With-Distributed-Leadership.html]Why Bother With Distributed Leadership?[/url]

If you have spent some time talking about non profit groups and being involved with fund-raisers. I would like to suggest that you should be take one step further and you should volunteer to be part of the executive.

Postage stamps are an adhesive label stuck on envelopes and other postal packages, as proof of the deposit of fee paid for postal services. The first country to issue postage stamps was United Kingdom.

Tags

Links

Main Subject - Why Bother With Distributed Leadership?

Related Articles: